相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus
Mark W. LaMere et al.
JOURNAL OF IMMUNOLOGY (2011)
Regulation of Antinucleoprotein IgG by Systemic Vaccination and Its Effect on Influenza Virus Clearance
Mark W. LaMere et al.
JOURNAL OF VIROLOGY (2011)
Cross-protective immunity to influenza A viruses
Suzanne L. Epstein et al.
EXPERT REVIEW OF VACCINES (2010)
The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen
Shiki Takamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses
Graeme E. Price et al.
PLOS ONE (2010)
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
Daniela Peruzzi et al.
VACCINE (2009)
Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
Graeme E. Price et al.
VACCINE (2009)
Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy
M. Dudareva et al.
VACCINE (2009)
Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Arturo Reyes-Sandoval et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus
Damian M. Carragher et al.
JOURNAL OF IMMUNOLOGY (2008)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1
Stephen Mark Tompkins et al.
EMERGING INFECTIOUS DISEASES (2007)
Immunogenicity of heterologous recombinant adenovirus prime-boost vaccine regimens is enhanced by circumventing vector cross-reactivity
Anna R. Thorner et al.
JOURNAL OF VIROLOGY (2006)
Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus
Yan Zhi et al.
HUMAN GENE THERAPY (2006)
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus
GP Kobinger et al.
VIROLOGY (2006)
Chimpanzee-origin adenovirus vectors as vaccine carriers
N Tatsis et al.
GENE THERAPY (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates
S Santra et al.
JOURNAL OF VIROLOGY (2005)
Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors
SM Sumida et al.
JOURNAL OF VIROLOGY (2004)
Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease
JS Smith et al.
GENE THERAPY (2004)
Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene:: Application in epidemiologic studies and in the design of adenovector vaccines
M Aste-Amézaga et al.
HUMAN GENE THERAPY (2004)
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes
ACM Boon et al.
JOURNAL OF IMMUNOLOGY (2004)
Development of stable liquid formulations for adenovirus- based vaccines
RK Evans et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors
S Roy et al.
HUMAN GENE THERAPY (2004)
T-cell response to adenovirus hexon and DNA-binding protein in mice
T McKelvey et al.
GENE THERAPY (2004)
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells
KA Benton et al.
JOURNAL OF IMMUNOLOGY (2001)
CD4+ T cell priming accelerates the clearance of Sendai virus in mice, but was a negative effect on CD8+ T cell memory
WM Zhong et al.
JOURNAL OF IMMUNOLOGY (2000)
Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge
SL Epstein et al.
INTERNATIONAL IMMUNOLOGY (2000)
Canine adenovirus vectors: an alternative for adenovirus mediated gene transfer
EJ Kremer et al.
JOURNAL OF VIROLOGY (2000)
分享论文
